|
Average achievement on each outcome and treatment indicator for England and differences from England for other countries (99% confidence intervals) |
||||
| Indicator |
England (%) |
Scotland % point difference from England (99% CI) |
Wales % point difference from England (99% CI) |
Northern Ireland % point difference from England (99% CI) |
|
|
||||
| Intermediate outcome |
||||
| CHD – blood pressure ≤ 150/90 |
84.1 |
1.1 (0.4 to 1.8) |
-0.8 (-2.1 to 0.2) |
3.5 (2.7 to 4.4) |
| Stroke – blood pressure ≤ 150/90 |
81.0 |
2.2 (1.2 to 3.1) |
-2.1 (-3.6 to -0.7) |
4.4 (3.2 to 5.4) |
| Hypertension – BP ≤ 150/90 |
71.4 |
0.9 (-0.1 to 1.8) |
-1.4 (-2.7 to -0.2) |
5.0 (3.8 to 6.2) |
| Diabetes – blood pressure ≤ 145/85 |
70.4 |
4.3 (3.3 to 5.2) |
-2.0 (-3.4 to -0.5) |
6.5 (5.4 to 7.8) |
| CHD – cholesterol ≤ 5 mmol/l |
72.2 |
-1.5 (-2.7 to -0.4) |
-1.8 (-3.5 to -0.2) |
-0.4 (-2.2 to 0.4) |
| Stroke – cholesterol ≤ 5 mmol/l |
62.7 |
2.4 (0.8 to 3.8) |
-3.7 (-6.1 to -1.4) |
2.8 (0.8 to 4.7) |
| Diabetes – cholesterol ≤ 5 mmol/l |
72.0 |
2.4 (1.4 to 3.4) |
0.3 (-1.1 to 1.7) |
3.7 (2.5 to 5.0) |
| Diabetes – HBA1c ≤ 7.4% |
59.0 |
-2.1 (-3.1 to -1.1) |
-1.6 (-2.7 to -0.4) |
-2.1 (-3.6 to -0.5) |
| Diabetes – HBA1c ≤ 10% |
89.5 |
0.6 (0.0 to 1.2) |
-1.0 (-2.0 to -0.1) |
1.1 (0.3 to 1.9) |
| Treatment |
||||
| CHD – on aspirin or equivalent |
90.2 |
-0.3 (-0.8 to 0.3) |
-1.5 (-2.5 to -0.8) |
1.7 (0.9 to 2.4) |
| CHD – on beta-blocker |
64.9 |
4.5 (3.4 to 5.7) |
-1.8 (-3.4 to -0.2) |
6.7 (4.9 to 8.6) |
| CHD – had influenza vaccination |
87.2 |
-0.4 (-1.4 to 0.6) |
-3.4 (-5.0 to -1.7) |
1.9 (0.6 to 3.2) |
| Stroke – had influenza vaccination |
84.0 |
0.2 (-0.8 to 1.3) |
-4.5 (-6.9 to -2.4) |
1.5 (-0.7 to 3.0) |
| Diabetes – had influenza vaccination |
74.4 |
-1.6 (-2.6 to -0.9) |
-4.3 (-5.6 to -3.0) |
3.2 (2.0 to 4.4) |
|
Note: Bold type = significant at P < 0.01 | ||||
McLean et al. BMC Health Services Research 2007 7:74 doi:10.1186/1472-6963-7-74 |
||||